PharmaShots | Incisive News in 3 Shots

Subscribe Now

AEON Biopharma

AEON Biopharma Reports P-II Trial Results of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine

AEON Biopharma Reports P-II Trial Results of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine

October 20, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us